Samsung Biologics Logo

Samsung Biologics

🇰🇷
207940
KR7207940008

Samsung Biologics, a global leading CDMO headquartered in South Korea, provides comprehensive services for the development and GMP-compliant manufacturing of biopharmaceutical drugs. The company supports pharmaceutical companies worldwide in the efficient production of high-quality biologics.

Next Quarterly Earnings

Tuesday, October 27, 2026
CW 44
Pre-Market
In 61 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on September 29, 2026

Stock Price

Frequently asked questions

When will Samsung Biologics report its next quarterly earnings?

Samsung Biologics is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Samsung Biologics last report quarterly earnings?

Samsung Biologics last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at 9,307.43 KRW.

How does Samsung Biologics stock react to earnings?

Across its last 5 earnings reports, Samsung Biologics stock moved by ±3.5% on average the following day. The largest reaction was +10.1% on 07/23/2026; 3 of 5 reactions were positive.

How often has Samsung Biologics beaten expectations?

Samsung Biologics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Samsung Biologics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:₩9,978.26
Actual:
Q2 2026
Missed
Estimate:₩9,684.42
Actual:₩9,307.43
Difference:-₩376.99
Price reaction (1 day):+10.1 %
Price reaction (7 days):+10.7 %
Q1 2026
Beat
Estimate:₩9,544.89
Actual:₩10,142.01
Difference:+₩597.12
Price reaction (1 day):-1.7 %
Price reaction (7 days):-7.2 %
Q4 2025
Missed
Estimate:₩11,382.97
Actual:₩11,017.27
Difference:-₩365.70
Price reaction (1 day):-2.5 %
Price reaction (7 days):-6.7 %
Q3 2025
Missed
Estimate:$10,335.52
Actual:$8,071.00
Difference:-$2,264.52
Price reaction (1 day):+2.0 %
Price reaction (7 days):+1.1 %
Q1 2025
Missed
Estimate:$7,073.89
Actual:$7,008.09
Difference:-$65.80
Q4 2024
Estimate:
Actual:
Price reaction (1 day):+1.3 %
Price reaction (7 days):+8.0 %

Earnings statistics

Stock reaction to earnings

±3.5%
Avg. next-day move
+10.1%
Largest move (07/23/2026)
60%
Share of positive reactions
±6.8%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-0.2%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Samsung Biologics
Ticker Symbol
207940
ISIN
KR7207940008
Country
🇰🇷
Korea, Republic of
Sector